drugset / Trial / NCT06559072
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
Phase 3
Not yet recruiting
522 enrolled
The George Institute
Tianjin Medical University General Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
A researcher-initiated and conducted multicenter, randomized controlled trial aimed at evaluating the efficacy and safety of ultra-early statin therapy in the treatment of acute aneurysmal subarachnoid hemorrhage (aSAH).
Timeline
- Start
- 2024-09-01
- Primary completion
- 2026-01-01
- Completion
- 2026-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |